| MicroRNA-155-5p diminishes in vitro ovarian cancer cell viability by targeting HIF1? expression | Q1 Journal | 0 | 7 | Advanced Pharmaceutical Bulletin | 2020 | 5 |
| Transcriptome related to avoiding immune destruction in nasopharyngeal cancer in indonesian patients using next-generation sequencing | Q2 Journal | 0 | 12 | Asian Pacific Journal of Cancer Prevention | 2020 | 1 |
| Transcriptome profile of next generation sequence data related to inflammation on nasopharyngeal carcinoma cases in Indonesia | Q2 Journal | 0 | 12 | Asian Pacific Journal of Cancer Prevention | 2020 | 4 |
| Transcriptome profile of next-generation sequencing data relate to proliferation aberration of nasopharyngeal carcinoma patients in Indonesia | Q2 Journal | 0 | 12 | Asian Pacific Journal of Cancer Prevention | 2020 | 1 |
| Circulation EBV mir-bart-7 relating to clinical manifestation in nasopharyngeal carcinoma | Q2 Journal | 0 | 8 | Asian Pacific Journal of Cancer Prevention | 2020 | 2 |
| The effects of combination of mimic miR-155-5p and antagonist miR-324-5p encapsulated chitosan in ovarian cancer SKOV3 | Q2 Journal | 0 | 7 | Asian Pacific Journal of Cancer Prevention | 2020 | 4 |
| Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer | Q2 Journal | 0 | 10 | Asian Pacific Journal of Cancer Prevention | 2020 | 5 |
| Upregulation of circulating MiR-21 expression as a potential biomarker for therapeutic monitoring and clinical outcome in breast cancer | Q2 Journal | 0 | 10 | Asian Pacific Journal of Cancer Prevention | 2019 | 16 |
| The expression of mir-21 and mir-29c in blood plasma of nasopharyngeal carcinoma patient post-chemoradiotherapy | no-Q Journal | 0 | 6 | Indian Journal of Public Health Research and Development | 2019 | 2 |
| Expression of micro RNA-21 and 29c in blood plasma of patients with nasopharyngeal carcinoma | Q3 Journal | 0 | 7 | Journal of Medical Sciences (Faisalabad) | 2017 | 1 |
| Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients | Q1 Journal | 0 | 14 | PLoS ONE | 2022 | 2 |